数亿融资到手！欣界能源 A 轮融资完成，产线扩建要来了

Investment Events - Xinjie Energy has completed a series A financing of several hundred million yuan, focusing on solid-state lithium metal battery development and production, with funds allocated for production line expansion and technology iteration [2] - Lingxin Qiaoshou announced the completion of a series A financing of several hundred million yuan, led by Ant Group, aimed at enhancing technology reserves and accelerating the application of embodied intelligence [3] - Huzhou Pharmaceutical has completed a series A financing of several tens of millions of dollars to advance its pipeline development in targeted radioligand therapy [4] - Zhi Nuo Technology successfully completed a Pre-A round financing of several tens of millions of yuan, focusing on biosynthetic high-value natural metabolites [5] - Dewo Intelligent has secured series A financing, with investments from Jinqiao Fund and Puxin Fund, focusing on IoT solutions and digital technology services [8] - Wuke Jingsi has completed a new round of financing led by Yumei Fund, focusing on silicon-based anode materials for lithium batteries [9] - Jiangxin New Materials received strategic investment from Evergrande Green Energy, focusing on silicon-carbon anode materials [10] - Yinnuo Pharmaceutical received $10 million in investment for its diabetes treatment product, with cornerstone investors participating in the share subscription [11] - Artificial Productivity completed seed round financing of several million dollars, focusing on AI and hardware integration [12] - Chuangzuo Shuzhi completed a new round of financing, focusing on smart charging management systems [13] - Weita Power completed angel round financing, focusing on innovative robotic products [14] - Newray Photomask received 50 million yuan in A+ round investment, focusing on advanced semiconductor photomask manufacturing [15] IPO Events - Dongyangguang Pharmaceutical has officially listed on the Hong Kong Stock Exchange, focusing on the development and commercialization of small molecule innovative drugs and biological innovative drugs [6][7]